Tower Urology,

Los Angeles, California 90078

2 studies enrolling now · 34 studies all time

What they study most

Advanced Prostate Cancer, Androgen Resistant Prostatic Cancer, Benign Prostatic Hyperplasia, Biochemical Recurrence of Malignant Neoplasm of Prostate, Biochemically Recurrent Prostate Cancer, Bladder Cancer, Bladder Cancer Cell Transitional, Cancer, Cystitis, Interstitial, Dietary Hyperoxaluria, Hyperoxaluria, Kidney Stones

Studies at this site

• LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve — Recruiting now
• Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer — Recruiting now
• A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer — Running, not enrolling
• A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer — Completed
• Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy — Completed
• A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX — Completed
• A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies — Running, not enrolling
• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling
• A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT — Running, not enrolling
• Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate — Completed
• A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study. — Running, not enrolling
• Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer — Completed
• 64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE) — Completed
• Comparing UroLift Experience Against Rezūm — Running, not enrolling
• Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence — Completed
• PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer — Running, not enrolling
• Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer — Completed
• Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer. — Completed
• A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy — Completed
• 64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA) — Completed
• Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent — Stopped early
• Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer — Completed
• A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer — Completed
• Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men — Completed
• Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer — Completed
• Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer — Completed
• Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence — Completed
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial) — Status unconfirmed
• Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer — Completed
• 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment — Completed
• Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men — Completed
• Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones — Completed
• A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome — Completed